Will you still treat me when i'm 64? Care of the older adult with hiv infection

Topics in Antiviral Medicine

Volumn 23, Issue 2, 2015, Pages 97-103

  Libman, Howard ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Age Related diseases; Aging; Bone loss; Cancer; Coronary artery disease; HIV; Mortality

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; LOPINAVIR PLUS RITONAVIR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PNEUMOCOCCUS VACCINE; RITONAVIR; TENOFOVIR; VARICELLA ZOSTER VACCINE;

ADULT; AGING; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; META ANALYSIS (TOPIC); MORTALITY; NEOPLASM; OSTEOLYSIS; PREMATURE AGING; RISK FACTOR; SMOKING; VACCINATION; AGED; BONE DISEASES; CARDIOVASCULAR DISEASES; COMPLICATION; HIV INFECTIONS; LONGEVITY; MIDDLE AGED; NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DISEASES; CARDIOVASCULAR DISEASES; HIV INFECTIONS; HUMANS; LONGEVITY; MIDDLE AGED; NEOPLASMS;

EID: 84953728206     PISSN: 21615861     EISSN: 21615853     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cao W, Jamieson BD, Hultin LE, Hultin PM, Effros RB, Detels R. Premature aging of T cells is associated with faster HIV-1 disease progression. JAIDS. 2009; 50(2): 137-147.
2. Centers for Disease Control and Prevention. Diagnoses of HIV Infection in the United States and Dependent Areas, 2013. http://www.cdc.gov/hiv/library/reports/surveillance/2013/surveillance: Report_vol_25.html. Accessed on May 20, 2015.
3. Althoff KN, Justice AC, Gange SJ, et al. Virologic and immunologic response to HAART, by age and regimen class. AIDS. 2010;24(16):2469-2479.
4. Grabar S, Kousignian I, Sobel A, et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS. 2004; 18(15): 2029-2038.
5. Ghidei L, Simone MJ, Salow MJ, et al. Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs Aging. 2013; 30(10):809-819.
6. Knobel H, Guelar A, Valldecillo G, et al. Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS. 2001;15(12):1591-1593.
7. Lodwick RK, Smith CJ, Youle M, et al. Stability of antiretroviral regimens in patients with viral suppression. AIDS. 2008; 22(9):1039-1046.
8. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011; 53(11):1120-1126.
9. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology. 2004;63(5):822-827.
10. Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med. 2010;153(7):452-460.
11. Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183(3):388-395.
12. Freiberg MS, Chang CC, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614-622.
13. Medapalli RK, Parikh CR, Gordon K, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. J Acquir Immune DeficSyndr. 2012;60(4):393-399.
14. Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335-344.
15. Framingham Heart Study. Cardiovascular disease (10-year risk), http://www.fram-inghamheartstudy.org/risk-functions/ cardiovascular-disease/ 10-y ear-risk. php. Accessed on May 20, 2015.
16. American Heart Association/American College of Cardiology. 2013 Prevention guidelines tools: CV risk calculator, https://my.americanheart.org/professional/StatementsGuidelines/Prevention-Guidelines_UCM_457698_SubHomePage.jsp. Accessed on May 20, 2015.
17. Bedimo R, Maalouf NM, Zhang S, Drechsler H, Tebas P. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS. 2012;26:825-831.
18. Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(l):el-34.
19. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal WklyRep. 2012;61 (40):816-819.
20. Centers for Disease Control and Prevention. Vaccines that might be indicated for adults based on medical and other indications: United States, 2015. http://www.cdc.gov/vaccines/schedules/hcp/imz/ adult-conditions.html. Accessed on June 24, 2015.
21. Benson C, Hua L, Andersen J et al. Zosta-vax is generally safe and immunogenic in HIV+ adults virologically suppressed on ART: results of a phase 2, randomized, double-blind, placebo-controlled trial [Abstract 96]. 19th Conference on Retroviruses and Opportunistic Infections (CROI). March 5-8, 2012; Seattle, Washington.
22. US Preventive Services Task Force. Depression in adults: screening. http://www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/depression-in-adults-screening. Accessed on June 11, 2015.
23. Centers for Disease Control and Prevention. Mortality slide series, http://www.cdc.gov/hiv/pdf/statistics_surveillance:HIV_ mortality.pdf. Accessed on May 21, 2015.
24. Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): amul-ticohort collaboration. Lancet. 2014;384 (9939):241-248.
25. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8(12):e81355.